[go: up one dir, main page]

PT3875599T - Métodos para deteção de subpopulações raras de células e composições altamente purificadas de células - Google Patents

Métodos para deteção de subpopulações raras de células e composições altamente purificadas de células

Info

Publication number
PT3875599T
PT3875599T PT211637681T PT21163768T PT3875599T PT 3875599 T PT3875599 T PT 3875599T PT 211637681 T PT211637681 T PT 211637681T PT 21163768 T PT21163768 T PT 21163768T PT 3875599 T PT3875599 T PT 3875599T
Authority
PT
Portugal
Prior art keywords
cells
detection
methods
highly purified
purified compositions
Prior art date
Application number
PT211637681T
Other languages
English (en)
Original Assignee
Astellas Inst For Regenerative Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Inst For Regenerative Medicine filed Critical Astellas Inst For Regenerative Medicine
Publication of PT3875599T publication Critical patent/PT3875599T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
PT211637681T 2010-07-23 2011-07-25 Métodos para deteção de subpopulações raras de células e composições altamente purificadas de células PT3875599T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36703810P 2010-07-23 2010-07-23
US41477010P 2010-11-17 2010-11-17

Publications (1)

Publication Number Publication Date
PT3875599T true PT3875599T (pt) 2025-01-22

Family

ID=45497502

Family Applications (2)

Application Number Title Priority Date Filing Date
PT118105188T PT2596119T (pt) 2010-07-23 2011-07-25 Métodos para a deteção de subpopulações raras de células e composições de células altamente purificadas
PT211637681T PT3875599T (pt) 2010-07-23 2011-07-25 Métodos para deteção de subpopulações raras de células e composições altamente purificadas de células

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT118105188T PT2596119T (pt) 2010-07-23 2011-07-25 Métodos para a deteção de subpopulações raras de células e composições de células altamente purificadas

Country Status (11)

Country Link
US (2) US11739366B2 (pt)
EP (3) EP2596119B8 (pt)
JP (5) JP6184865B2 (pt)
AU (1) AU2011280878B2 (pt)
CA (1) CA2806127C (pt)
DK (2) DK2596119T3 (pt)
ES (2) ES2874953T3 (pt)
HU (1) HUE054517T2 (pt)
PL (2) PL3875599T3 (pt)
PT (2) PT2596119T (pt)
WO (1) WO2012012803A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2438815A3 (en) 2004-01-23 2012-10-03 Advanced Cell Technology, Inc. Improved modalities for the treatment of degenerative diseases of the retina
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
KR101849336B1 (ko) 2007-10-12 2018-04-16 아스텔라스 인스티튜트 포 리제너러티브 메디슨 Rpe 세포의 개선된 생산 방법 및 rpe 세포의 조성물
DK2499236T3 (da) 2009-11-12 2020-03-23 Technion Res & Dev Foundation Dyrkningsmedier, cellekulturer og metoder til dyrkning af pluripotente stamceller i en udifferentieret tilstand
IL281453B (en) 2009-11-17 2022-07-01 Astellas Inst For Regenerative Medicine Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells
ES2874953T3 (es) 2010-07-23 2021-11-05 Astellas Inst For Regenerative Medicine Métodos para la detección de subpoblaciones raras de células y composiciones muy purificadas de células
JP6506023B2 (ja) * 2011-11-14 2019-04-24 アステラス インスティテュート フォー リジェネレイティブ メディシン ヒトrpe細胞医薬品およびその使用
TR201903889T4 (tr) * 2011-12-06 2019-04-22 Astellas Inst For Regenerative Medicine Korneal endotelyal hücreler üreten yönlendirilmiş diferansiyasyona yönelik yöntem.
JP6090735B2 (ja) * 2012-03-02 2017-03-08 国立大学法人山口大学 消化器系がん幹細胞を培養するための無血清培地、及びそれを用いた消化器系がん幹細胞の増殖方法
HK1208371A1 (en) * 2012-10-09 2016-03-04 桑比欧公司 Methods and compositions for treatment of retinal degeneration
EP2980585B1 (en) * 2013-03-29 2019-11-20 Mie University Vital stain
WO2015045962A1 (ja) * 2013-09-26 2015-04-02 コニカミノルタ株式会社 組織切片における生体物質の定量法
CN106574245A (zh) * 2014-06-10 2017-04-19 保利比奥斯博特有限公司 用于细胞免疫治疗的培养基
JP6271407B2 (ja) * 2014-12-17 2018-01-31 富士フイルム株式会社 細胞評価統合方法
JP6459568B2 (ja) * 2015-01-30 2019-01-30 コニカミノルタ株式会社 目的細胞の検出方法および目的細胞検出システム
CN104833805A (zh) * 2015-03-09 2015-08-12 武汉格蓝丽富科技有限公司 一种循环肿瘤细胞检测和鉴定试剂盒及其应用
EP3274710B1 (en) 2015-03-23 2021-06-09 Astellas Institute for Regenerative Medicine Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors
JP7043392B2 (ja) 2015-08-18 2022-03-29 アステラス インスティテュート フォー リジェネレイティブ メディシン 臨床製剤
WO2017100498A1 (en) 2015-12-11 2017-06-15 The Johns Hopkins University Isolation of fusion-competent myoblasts and therapeutic applications thereof related to muscular dystrophy
CN106053196B (zh) * 2016-05-23 2019-02-15 无锡帝科电子材料股份有限公司 一种光伏正面银浆用银粉粒度测试的分散方法
CN106525541B (zh) * 2016-09-20 2019-01-18 广东东阳光药业有限公司 一种鲜冬虫夏草细胞活力的检测方法
EP4467565A3 (en) 2016-12-21 2025-03-12 Amgen Inc. Anti-tnf alpha antibody formulations
CN110506109B (zh) 2017-06-05 2024-03-12 泰尔茂株式会社 细胞培养物的制造方法
WO2020067438A1 (ja) 2018-09-27 2020-04-02 国立大学法人大阪大学 多能性幹細胞由来細胞のシート化方法
KR102224273B1 (ko) * 2019-10-10 2021-03-08 고려대학교 산학협력단 줄기세포 유래 성숙 심근세포 및 이를 이용한 심혈관 질환 모델
CA3158763A1 (en) 2019-10-30 2021-05-06 Astellas Institute For Regenerative Medicine Methods for producing retinal pigment epithelium cells
CN112461807B (zh) * 2020-11-26 2021-11-19 山西大学 碳量子点在靶向细胞核仁免洗成像中的应用

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7A (en) 1836-08-10 Thomas Blanchard Machine for boring holes and cutting lanyard-scores in deadeyes
US5610753A (en) 1991-12-12 1997-03-11 Eastman Kodak Company Optical design of laser scanner to reduce thermal sensitivity
US5780300A (en) * 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
JP2000505294A (ja) 1996-02-16 2000-05-09 ザ ユニバーシティ オブ エディンバラ 分化の阻害のためのdia/lif―欠損胚幹細胞により発現されるサイトカイン
DE19609838A1 (de) * 1996-03-13 1997-09-18 Boehringer Mannheim Gmbh Verfahren und Teststreifen zur Bestimmung eines Analyten
FR2754544B1 (fr) 1996-10-10 1998-11-06 Lorraine Laminage Tole aluminiee a faible emissivite
WO1999012572A1 (en) 1997-09-10 1999-03-18 University Of Florida Compounds and method for the prevention and treatment of diabetic retinopathy
WO1999020741A1 (en) 1997-10-23 1999-04-29 Geron Corporation Methods and materials for the growth of primate-derived primordial stem cells
US6322901B1 (en) 1997-11-13 2001-11-27 Massachusetts Institute Of Technology Highly luminescent color-selective nano-crystalline materials
AU2884499A (en) * 1998-03-02 1999-09-20 Compucyte Corp. Selective cell analysis
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US6943153B1 (en) 1999-03-15 2005-09-13 The Regents Of The University Of California Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US8044259B2 (en) 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US20080194022A1 (en) 2000-08-03 2008-08-14 Clarke Michael F Isolation and use of solid tumor stem cells
US6649138B2 (en) 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
WO2002043785A2 (en) 2000-11-29 2002-06-06 Oculex Pharmaceuticals, Inc. Intraocular implants for preventing transplant rejection in the eye
US6576291B2 (en) 2000-12-08 2003-06-10 Massachusetts Institute Of Technology Preparation of nanocrystallites
US20020083888A1 (en) 2000-12-28 2002-07-04 Zehnder Donald A. Flow synthesis of quantum dot nanocrystals
CA2436448A1 (en) 2001-02-02 2002-08-15 Dana-Farber Cancer Institute, Inc. Rare event detection system
EP1666881B1 (en) * 2001-05-04 2010-02-17 Biosite Incorporated Diagnostic markers of acute coronary syndromes and methods of use thereof
GB2393734B (en) * 2001-07-12 2005-07-27 Geron Corp Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
JP4567436B2 (ja) 2001-07-20 2010-10-20 ライフ テクノロジーズ コーポレーション 発光ナノ粒子およびそれらの調製方法
JP2005514004A (ja) 2001-08-23 2005-05-19 リライアンス ライフ サイエンシイズ ピーヴィーティー., エルティーディー ヒト胚性幹細胞(hESC)株の樹立のための内部細胞塊の単離
CA2468292A1 (en) 2001-11-26 2003-06-05 Advanced Cell Technology, Inc. Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
WO2003060083A2 (en) 2002-01-15 2003-07-24 Advanced Cell Technology, Inc. Cloning b and t lymphocytes
US20040091936A1 (en) 2002-05-24 2004-05-13 Michael West Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
US7662625B2 (en) 2002-07-02 2010-02-16 Cancer Research Technology Limited Methods for detecting the differentiation status of cells using 5T4 antigen expression
CA2505743A1 (en) * 2002-11-14 2004-06-03 Ethicon Endo-Surgery, Inc. Methods and devices for detecting tissue cells
EP1599730A2 (en) * 2003-03-03 2005-11-30 Kouyama, Yoshihisa Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
JP4740862B2 (ja) 2003-05-07 2011-08-03 インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション 合金化された半導体量子ドットおよび合金化された濃度勾配量子ドット、これらの量子ドットを含むシリーズ、ならびにこれらに関する方法
US20050118713A1 (en) * 2003-05-12 2005-06-02 Nikolai Strelchenko Morula derived embryonic stem cells
KR100657891B1 (ko) 2003-07-19 2006-12-14 삼성전자주식회사 반도체 나노결정 및 그 제조방법
KR100569168B1 (ko) * 2003-08-08 2006-04-07 (주)아비코아생명공학연구소 조류 정원줄기세포의 배양방법 및 이에 의해 수득한 조류정원줄기세포
EP2438815A3 (en) 2004-01-23 2012-10-03 Advanced Cell Technology, Inc. Improved modalities for the treatment of degenerative diseases of the retina
US20190282622A1 (en) 2004-01-23 2019-09-19 Astellas Institute For Regenerative Medicine Modalities for the treatment of degenerative diseases of the retina
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
KR101264940B1 (ko) 2004-09-08 2013-05-15 위스콘신 얼럼나이 리서어치 화운데이션 배아 줄기 세포용 배지 및 이의 배양물
AU2005304978A1 (en) 2004-11-04 2006-05-18 Advanced Cell Technology, Inc. Derivation of embryonic stem cells
US7893315B2 (en) 2004-11-04 2011-02-22 Advanced Cell Technology, Inc. Derivation of embryonic stem cells and embryo-derived cells
WO2007053648A2 (en) 2005-10-31 2007-05-10 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US20070160974A1 (en) 2006-01-10 2007-07-12 South Eastern Sydney And Illawarra Area Health Service Human embryonic stem cell clones
CZ301148B6 (cs) * 2006-01-25 2009-11-18 Univerzita Karlova V Praze Zpusob pestování lidských mezenchymových kmenových bunek, zejména pro lécbu nehojících se fraktur, a bioreaktor k provádení tohoto zpusobu
CN101405399A (zh) 2006-03-16 2009-04-08 健康研究股份有限公司 抑制乳腺癌干细胞的生长和转移
KR100832592B1 (ko) 2006-08-17 2008-05-27 박현숙 폴리머 막을 이용한 줄기세포와 피더세포의 공배양방법
AU2008207945A1 (en) 2007-01-22 2008-07-31 Macrogenics West, Inc. Human cancer stem cells
US8097588B2 (en) * 2007-02-08 2012-01-17 Sanford-Burnham Medical Research Institute Trophinin-binding peptides and uses thereof
EP3640326A1 (en) 2007-04-18 2020-04-22 Hadasit Medical Research Services & Development Limited Stem cell-derived retinal pigment epithelial cells
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
KR101849336B1 (ko) 2007-10-12 2018-04-16 아스텔라스 인스티튜트 포 리제너러티브 메디슨 Rpe 세포의 개선된 생산 방법 및 rpe 세포의 조성물
HU0700675D0 (en) * 2007-10-15 2007-12-28 Mta Tamogatott Kutatohelyek Ir Method for monitoring stem cell differentiation
US20090123439A1 (en) * 2007-11-09 2009-05-14 The Jackson Laboratory Diagnostic and prognosis methods for cancer stem cells
US20090233324A1 (en) * 2008-03-11 2009-09-17 Kopf-Sill Anne R Methods for Diagnosing Cancer Using Samples Collected From A Central Vein Location or an Arterial Location
IL281453B (en) 2009-11-17 2022-07-01 Astellas Inst For Regenerative Medicine Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells
ES2874953T3 (es) 2010-07-23 2021-11-05 Astellas Inst For Regenerative Medicine Métodos para la detección de subpoblaciones raras de células y composiciones muy purificadas de células
US20120258451A1 (en) 2011-04-08 2012-10-11 Advanced Cell Technology, Inc. Laser isolation of viable cells
JP6506023B2 (ja) 2011-11-14 2019-04-24 アステラス インスティテュート フォー リジェネレイティブ メディシン ヒトrpe細胞医薬品およびその使用
EP3274710B1 (en) 2015-03-23 2021-06-09 Astellas Institute for Regenerative Medicine Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors

Also Published As

Publication number Publication date
JP2022095696A (ja) 2022-06-28
PL2596119T3 (pl) 2021-12-06
DK2596119T3 (da) 2021-07-26
US20240026419A1 (en) 2024-01-25
EP2596119A4 (en) 2013-12-04
JP7412470B2 (ja) 2024-01-12
ES2874953T3 (es) 2021-11-05
DK3875599T3 (da) 2025-01-20
EP2596119B1 (en) 2021-04-28
EP4524568A3 (en) 2025-06-18
JP2013535194A (ja) 2013-09-12
EP2596119B8 (en) 2021-06-02
US11739366B2 (en) 2023-08-29
JP2017079752A (ja) 2017-05-18
AU2011280878B2 (en) 2016-06-16
PL3875599T3 (pl) 2025-03-24
PT2596119T (pt) 2021-06-18
WO2012012803A2 (en) 2012-01-26
EP3875599B1 (en) 2024-12-11
JP7788436B2 (ja) 2025-12-18
JP2020048573A (ja) 2020-04-02
JP6184865B2 (ja) 2017-08-23
EP2596119A2 (en) 2013-05-29
ES3013241T3 (en) 2025-04-11
JP6630657B2 (ja) 2020-01-15
HUE054517T2 (hu) 2021-09-28
JP7125382B2 (ja) 2022-08-24
WO2012012803A3 (en) 2012-11-01
CA2806127C (en) 2021-12-21
JP2024026528A (ja) 2024-02-28
CA2806127A1 (en) 2012-01-26
EP4524568A2 (en) 2025-03-19
EP3875599A1 (en) 2021-09-08
US20130302824A1 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
PL2596119T3 (pl) Sposoby wykrywania rzadkich subpopulacji komórek i kompozycje wysoko oczyszczonych komórek
ZA201304337B (en) Soybean event syht0h2 and compositions and methods for detection thereof
EP2526183A4 (en) Magnetic separation of rare cells
SG10201506767QA (en) Identification and enrichment of cell subpopulations
SI2533761T1 (sl) Postopki in sestavki za pripravo aerosolov
AP2013006950A0 (en) Compositions and methods for detection and management of malaria
EP2577536A4 (en) Methods and compositions for predicting unobserved phenotypes (pup)
IL274395B (en) Subpopulations of spore-like cells and their uses
GB201005675D0 (en) System for the detection of incoming muntions
SG10201509539UA (en) Methods And Compositions For Inhibition Of Treg Cells
GB201018650D0 (en) Methods and compositions
EP2536799A4 (en) Laminated compositions and methods
IL223223A0 (en) Compositions and methods for reduction of mercury toxicity
EP2614162A4 (en) DETECTION OF A CHROMATIN STRUCTURE
EP2805962A4 (en) IMMUNOMODULATORY METALLOPEPTIDES (IMMP) AND COMPOSITIONS CONTAINING THE SAME
WO2012162108A9 (en) Boron-containing compositions and methods therefor
AU2010901300A0 (en) Methods for detection of doping and compositions thereof
GB201104361D0 (en) Presymptomatic detection of infection in an individual
IL221023A0 (en) Magnetic separation of rare cells
LU91725B1 (en) Novel uses of V-ATPASE inhibitors
HK1184713A (en) METHODS AND COMPOSITIONS FOR CNS DELIVERY OF β-GALACTOCEREBROSIDASE
AU2010902782A0 (en) An enclosure for transporting people to and from high-altitudes
HK1166274A (en) Methods and compositions for the detection of cancer
HU1000631D0 (en) Methods compositions and processes for reducing/eliminating gastrointestinal dyscomfort
GB201008592D0 (en) Detection of gases